Neuroprotection of MPTP-induced toxicity in zebrafish dopaminergic neurons.

Parkinson's disease is characterized by a severe loss of dopaminergic neurons resulting in a range of motor deficits. The neurotoxin 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) is known to cause a similar loss of dopaminergic neurons in the human midbrain with corresponding Parkinsonian symptoms. Several animal species have also shown sensitivity to MPTP, including primates, mice, goldfish, and, most recently, zebrafish. This study demonstrates that the effect of MPTP on dopaminergic neurons in zebrafish larvae is mediated by the same pathways that have been demonstrated in mammalian species. MPTP-induced neurodegeneration was prevented by co-incubation with either the monoamine oxidase-B (MAO-B) inhibitor l-deprenyl or the dopamine transporter (DAT) inhibitor nomifensine. Furthermore, targeted inactivation of the DAT gene by antisense morpholinos also protected neurons from MPTP damage. Thus, the mechanism for MPTP-induced dopaminergic neuron toxicity in mammals is conserved in zebrafish larvae. Effects on swimming behavior and touch response that result from MPTP damage are partially ameliorated by both l-deprenyl and DAT knockdown.

[1]  P. Ma Catecholaminergic systems in the zebrafish. III. organization and projection pattern of medullary dopaminergic and noradrenergic neurons , 1997, The Journal of comparative neurology.

[2]  M. Wullimann,et al.  The teleostean (zebrafish) dopaminergic system ascending to the subpallium (striatum) is located in the basal diencephalon (posterior tuberculum) , 2001, Brain Research.

[3]  M. Ebadi,et al.  Neuroprotective actions of selegiline , 2002, Journal of neuroscience research.

[4]  T. Dawson,et al.  Oxidative Stress and Genetics in the Pathogenesis of Parkinson's Disease , 2000, Neurobiology of Disease.

[5]  A. Setini,et al.  Molecular characterization of monoamine oxidase in zebrafish (Danio rerio). , 2005, Comparative biochemistry and physiology. Part B, Biochemistry & molecular biology.

[6]  David H. Hall,et al.  Neurotoxin-induced degeneration of dopamine neurons in Caenorhabditis elegans , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[7]  J. Schulz,et al.  Parkinson's disease: one biochemical pathway to fit all genes? , 2002, Trends in molecular medicine.

[8]  S. Ekker,et al.  Effective targeted gene ‘knockdown’ in zebrafish , 2000, Nature Genetics.

[9]  T. Sherer,et al.  Animal models of Parkinson's disease. , 2002, BioEssays : news and reviews in molecular, cellular and developmental biology.

[10]  J. Postlethwait,et al.  Structure of the zebrafish snail1 gene and its expression in wild-type, spadetail and no tail mutant embryos. , 1993, Development.

[11]  W. Driever,et al.  Mutations in the zebrafish unmask shared regulatory pathways controlling the development of catecholaminergic neurons. , 1999, Developmental biology.

[12]  R. Gainetdinov,et al.  Dopamine Transporter Is Required for In Vivo MPTP Neurotoxicity: Evidence from Mice Lacking the Transporter , 1997, Journal of neurochemistry.

[13]  G. Petzinger,et al.  The parkinsonian toxin 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine (MPTP): a technical review of its utility and safety , 2001, Journal of neurochemistry.

[14]  J. Dowling,et al.  Small molecule developmental screens reveal the logic and timing of vertebrate development. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[15]  J. Langston,et al.  Chronic Parkinsonism in humans due to a product of meperidine-analog synthesis. , 1983, Science.

[16]  H. Pollard,et al.  Effect of MPTP on dopaminergic neurons in the goldfish brain: a light and electron microscope study , 1995, Brain Research.

[17]  David Blum,et al.  Molecular pathways involved in the neurotoxicity of 6-OHDA, dopamine and MPTP: contribution to the apoptotic theory in Parkinson's disease , 2001, Progress in Neurobiology.

[18]  K. Chiba,et al.  Metabolism of the neurotoxic tertiary amine, MPTP, by brain monoamine oxidase. , 1984, Biochemical and biophysical research communications.

[19]  Peter T Lansbury,et al.  Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in cell biology.

[20]  Su Guo,et al.  Sensitivity of zebrafish to environmental toxins implicated in Parkinson's disease. , 2004, Neurotoxicology and teratology.

[21]  Stuart L Schreiber,et al.  Chemical suppression of a genetic mutation in a zebrafish model of aortic coarctation , 2004, Nature Biotechnology.

[22]  T. Gasser Genetics of Parkinson's disease , 2001, Journal of Neurology.

[23]  S. Parvez,et al.  Cell death induced by MPTP, a substrate for monoamine oxidase B. , 2000, Toxicology.

[24]  U. Langheinrich,et al.  Zebrafish: a new model on the pharmaceutical catwalk. , 2003, BioEssays : news and reviews in molecular, cellular and developmental biology.

[25]  J. O. Schenk,et al.  Kinetic Evaluation of the Commonality Between the Site(s) of Action of Cocaine and Some Other Structurally Similar and Dissimilar Inhibitors of the Striatal Transporter for Dopamine , 1994, Journal of neurochemistry.

[26]  F. Vaglini,et al.  Species differences in the role of excitatory amino acids in experimental parkinsonism , 1997, Neuroscience & Biobehavioral Reviews.

[27]  P. Ma Catecholaminergic systems in the zebrafish. IV. Organization and projection pattern of dopaminergic neurons in the diencephalon , 2003, The Journal of comparative neurology.

[28]  J. Bloch,et al.  Neurodegeneration prevented by lentiviral vector delivery of GDNF in primate models of Parkinson's disease. , 2000, Science.

[29]  S. Mandel,et al.  MPTP and 6-hydroxydopamine-induced neurodegeneration as models for Parkinson’s disease: neuroprotective strategies , 2000, Journal of Neurology.

[30]  A. Rubinstein,et al.  Zebrafish: from disease modeling to drug discovery. , 2003, Current opinion in drug discovery & development.

[31]  P. Ma,et al.  Consistency in the number of dopaminergic paraventricular organ-accompanying neurons in the posterior tuberculum of the zebrafish brain , 2003, Brain Research.

[32]  F. Menniti,et al.  Pramipexole inhibits MPTP toxicity in mice by dopamine D3 receptor dependent and independent mechanisms. , 2003, European journal of pharmacology.

[33]  Calum A. MacRae,et al.  Drugs That Induce Repolarization Abnormalities Cause Bradycardia in Zebrafish , 2003, Circulation.

[34]  Todd B. Sherer,et al.  Chronic systemic pesticide exposure reproduces features of Parkinson's disease , 2000, Nature Neuroscience.

[35]  J. Fetcho,et al.  Ontogeny and innervation patterns of dopaminergic, noradrenergic, and serotonergic neurons in larval zebrafish , 2004, The Journal of comparative neurology.

[36]  M. Wullimann,et al.  Development of the catecholaminergic system in the early zebrafish brain: an immunohistochemical study. , 2002, Brain research. Developmental brain research.

[37]  Jan Kaslin,et al.  Neurochemical and behavioural changes in zebrafish Danio rerio after systemic administration of 6‐hydroxydopamine and 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine , 2003, Journal of neurochemistry.

[38]  E. Rink,et al.  The too few mutant selectively affects subgroups of monoaminergic neurons in the zebrafish forebrain , 2004, Neuroscience.

[39]  R. Blakely,et al.  The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. , 1998, Molecular pharmacology.

[40]  R. Gainetdinov,et al.  Plasma membrane monoamine transporters: structure, regulation and function , 2003, Nature Reviews Neuroscience.

[41]  V. Korzh,et al.  Zebrafish embryos are susceptible to the dopaminergic neurotoxin MPTP , 2005, The European journal of neuroscience.

[42]  Erwan Bezard,et al.  Absence of MPTP-Induced Neuronal Death in Mice Lacking the Dopamine Transporter , 1999, Experimental Neurology.

[43]  A. Levey,et al.  Dopamine transporters and neuronal injury. , 1999, Trends in pharmacological sciences.

[44]  S. Markey,et al.  A parkinsonian syndrome induced in the goldfish by the neurotoxin MPTP , 1992, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[45]  P. Lansbury,et al.  Genetics of Parkinson's disease and biochemical studies of implicated gene products. , 2002, Current opinion in genetics & development.

[46]  Wolfgang Driever,et al.  Dopamine transporter expression distinguishes dopaminergic neurons from other catecholaminergic neurons in the developing zebrafish embryo , 2001, Mechanisms of Development.